Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Gastrointestinal
»
Inflammatory Bowel Disease
04. May 2026
Search
medline.ch
Inflammatory Bowel Disease
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2873
Articles 1 - 20 / 57452
Selective IL-23 inhibitors in ulcerative colitis: current evidence and perspectives for multimodal personalized treatment: a narrative review.
J Gastroenterol
Horiuchi I, Horiuchi A, Sugimoto K.
PMID: 42068359 [PubMed - as supplied by publisher]
Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with noncomplicated or complex Crohn's disease: results from the EVOLVE Expansion study.
Eur J Gastroenterol Hepatol
Ferrante M, Christensen B, Bressler B, Bassel M, Brett NR, Gianchetti L, Kamble P, Adsul S, Farhat Z, Scharl M.
PMID: 42065987 [PubMed - as supplied by publisher]
What are the top 10 global research priorities for perianal Crohn's disease? The Global Perianal Crohn's Disease Priority Setting Partnership.
J Crohns Colitis
Pelly T, Anand E, Gower J, Mannick S, Hough T, Markham S, Sebastian S, Buskens C, Mccurdy JD, Deepak P, Radmard AR, Stoker J, Lung P, Kotze PG, Younge L, Robinson D, Joshi S, Shakweh E, Hanna L, Singh H, Khan Y, Nightingale K, Powell N, Tozer P, Hart A, PSP Collaborators.
PMID: 42065871 [PubMed - indexed for MEDLINE]
Exclusive enteral nutrition for induction of remission in Crohn's disease in adults: A systematic review and meta-analysis of randomized trials and real-world studies.
Indian J Gastroenterol
Kaur K, Singh A, Kaur S, Sharma R, Malik S, Bhardwaj A, Jena A, Mahajan R, Midha V, Sood A.
PMID: 42065851 [PubMed - as supplied by publisher]
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.
Inflamm Bowel Dis
Afzali A, Danese S, Panaccione R, Rubin DT, Sands BE, Reinisch W, Panés J, Van Rampelbergh R, Terry NA, Salese L, Vetter ML, Yee J, Corbett C, van Duijnhoven W, Hisamatsu T, Andrews JM, D'Haens GR, GALAXI 1 investigators.
PMID: 42065683 [PubMed - as supplied by publisher]
Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.
Am J Gastroenterol
Lichtenstein GR, Allegretti JR, Rubin DT, Magro F, Bressler B, Panés J, Afif W, Samaan MA, Ye BD, Yarandi S, Germinaro M, Shipitofsky N, Miao Y, Zhang H, Dignass A, Sands BE, Hisamatsu T, Peyrin-Biroulet L.
PMID: 42065421 [PubMed - as supplied by publisher]
The impact of dietary interventions on quality of life in adults with inflammatory bowel disease: a narrative review.
J Nutr Sci
McGuire R, Knol LL, Douglas J.
PMID: 42064993 [PubMed - indexed for MEDLINE]
Legume Consumption in Relation to Ulcerative Colitis: A Case-Control Study.
Curr Ther Res Clin Exp
Amini MR, Khademi Z, Samarin MM, Salavatizadeh M, Kalantar Z, Lohrasbi N, Ebrahimi-Daryani N, Esmaillzadeh A, Hekmatdoost A.
PMID: 42064684 [PubMed]
Thalidomide-mediated immunomodulation in a patient with IL-10RA deficiency-associated very early-onset inflammatory bowel disease.
Front Immunol
Ren A, Zeng Q, Zhang B, Chuan X, Wu Y, Wang M, Ren H, Chen Y, Huang P, Du Z.
PMID: 42064076 [PubMed - indexed for MEDLINE]
Shared molecular features and potential diagnostic biomarkers between ulcerative colitis and sarcopenia: an integrative bioinformatics analysis with preliminary experimental validation.
Front Immunol
Deng B, Liu Y, He P, Wang N, Xu L, Ma J.
PMID: 42064059 [PubMed - indexed for MEDLINE]
Case Report: Successful anti-TNF antibody therapy in steroid-dependent segmental colitis associated with diverticulosis and concomitant ulcerative colitis.
Front Immunol
Fousekis F, Siebler J, Rath T, Hartmann A, Neurath MF, Vieth M, Atreya R.
PMID: 42064046 [PubMed - indexed for MEDLINE]
Colorectal cancer in ulcerative colitis: unraveling mechanisms and advancing surveillance and chemoprevention.
Front Oncol
Lu H, Hu X, Chen Y, He J.
PMID: 42063710 [PubMed]
Escherichia coli pathobionts and Crohn's disease: varied genetic paths leading to similar phenotypes.
J Bacteriol
Arroyo-Mendoza M, Lorenzi H, Phillips GJ, Hinton DM.
PMID: 42060842 [PubMed - as supplied by publisher]
Safety and efficacy of oral tacrolimus induction therapy in elderly patients with ulcerative colitis: A subanalysis of a large multicenter retrospective cohort study.
Gerontology
Inokuchi T, Hiraoka S, Oshima N, Hayashi R, Takahashi S, Matsumoto H, Hashimoto S, Yashima K, Yamashita K, Inaba T, Kawashima K, Takami T, Isomoto H, Shiotani A, Oka S, Ishihara S, Otsuka M.
PMID: 42060557 [PubMed - as supplied by publisher]
Correction: Deep remission improves the quality of life of patients with Crohn's disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study.
Tech Coloproctol
Fathallah N, Akaffou M, Haouari MA, Spindler L, Alam A, Barré A, Pommaret E, Fels A, de Parades V.
PMID: 42060136 [PubMed - in process]
Sexual dysfunction is highly prevalent in patients with active perianal fistulizing Crohn's disease: Outcomes from a large national prospective cohort study.
Colorectal Dis
Bak MTJ, de Vries AC, Stassen LPS, Ter Kuile MM, van der Meulen-de Jong AE, van Ruler O, ALERT.
PMID: 42059297 [PubMed - indexed for MEDLINE]
Integrative eQTL and Mendelian Randomization Analyses with Experimental Validation Prioritize Genetic Candidate Biomarkers for Crohn's Disease.
Endocr Metab Immune Disord Drug Targets
Zhang X, Liu L, Xu W, Li G, Qin Q, Zhang J.
PMID: 42059218 [PubMed - as supplied by publisher]
Intestinal barrier dysfunction and differential CLDN8 and MUC1 expression in vedolizumab responsiveness among inflammatory bowel disease patients: a proof-of-concept study.
Malays J Pathol
Shahabudin NA, Raja Ali RA, Tan GC, Mokhtar NM.
PMID: 42059166 [PubMed - indexed for MEDLINE]
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.
United European Gastroenterol J
Iborra M, Botella B, Martín-Arranz MD, Ceballos D, Martínez-Pascual C, Garrido A, Varela P, Moreta M, Brunet-Mas E, González-Lama Y, Rodríguez-González E, Vicuña M, Gisbert JP, Ordás I, Argüelles-Arias F, Tosca-Cuquerella J, Vicente-Lidón R, Sierra-Ausín M, Rodríguez-Lago I, Martín-Rodríguez D, Paredes JM, Sicilia B, García de la Filia I, Jiménez N, Barreiro-de Acosta M, Betoré E, Ferrer-Bradley I, García-Alles L, Huguet JM, Castellet-Farrús S, García MJ, Gutiérrez-Casbas A, Ponferrada-Díaz Á, Ramos L, Calafat M, Vera I, Suárez-Ferrer C, Fernández-Velado E, Rodríguez-Sánchez S, Mínguez A, Mancebo A, Barrio J, Lario S, de La Cruz DR, Hernández-Camba A, Rodríguez-Gutiérrez C, Chaparro M, Ricart E, Almenara-Michelena L, Balaguer A, Domènech E, Nos P.
PMID: 42057704 [PubMed - indexed for MEDLINE]
Association of Crohn's disease with periodontal disease risk and severity: a meta-analytic study.
Acta Odontol Scand
Jin Y, Duan S, Chu W, Shen W.
PMID: 42057450 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 57452
Page 1 of 2873
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy